At ValveXchange, we’re developing an innovative new heart valve that, unlike its predecessors, is suitable for patients of all ages, and that does not condemn patients to a lifetime of drug therapy and sedentary lifestyle. ValveXchange has developed and clinically tested a revolutionary two-part bioprosthetic heart valve. Originally founded by noted heart valve scientist, Dr. Ivan Vesely, the Company has a decades long history and foundation in heart valve research. Our work has been supported initially by $2.5 Million in grants from the National Institutes of Health and others, and subsequent by private and strategic investments. We have a top-tier management team and a Medical Advisory Board that rivals that of established heart valve companies.